The lowest doses of Eli Lilly’s Zepbound and Novo Nordisk's Wegovy could be available for as little as $149 a month.
Investor's Business Daily on MSN
Novo Sweetens Its Bid For Metsera As Takeover Drama With Pfizer Escalates
Novo Nordisk said it would pay up to $10 billion to acquire obesity-focused Metsera, topping Pfizer's recently hiked $8.1 ...
Two years later, those treatments have thrust Metsera to the centre of a fierce takeover battle, with Ozempic maker Novo Nordisk and Pfizer willing to pay up to $10bn for the company. Both once again ...
Whanganui, NZ | Whanganui’s Te Whare Tūhua o Te Ao, New Zealand Glassworks (NZG) is excited to announce Lewis Batchelar as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback